BriaCell Therapeutics (BCTX) Stock Price, Quote, News & History | Benzinga

BriaCell Therapeutics Corp (BCTX) Stock Price, Quote, News & History

BCTXNASDAQ

Trade with Public

Trade with Public

$3.44

N/A

At close: Aug 14, 5:00 PM EST

$3.39

-0.05-1.45%

After Hours: 5:17 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Stock Report

Key Statistics

Open

$3.49

Close

$3.44

Volume / Avg.

40.50K / 198.55K

Day Range

$3.36 - $3.49

52 Wk Range

2.60 - 14.68

Market Cap

$29.49M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

4.7%

Days to Cover

5.95

Recent Briacell Therapeutics Corp News

Crude Oil Gains Over 1%; US Retail Sales Rise 0.6% In November

Avi Kapoor

Nasdaq Falls Over 100 Points; Bank of America Posts Upbeat Earnings

Avi Kapoor

Glaukos, Trip.com Group And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session

Avi Kapoor

What's Going On With BriaCell Therapeutics Stock Wednesday?

BriaCell Therapeutics stock surges with positive news of patient's complete resolution of lung metastasis in Bria-OTS study.

Vandana Singh

Why Gelteq Shares Are Trading Higher By 50%; Here Are 20 Stocks Moving Premarket

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-30.82M

Investing Cash Flow (TTM)

-16.19M

Financing Cash Flow (TTM)

41.43M

Free Cash Flow (TTM)

-30.95M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

-5.58M

Analyst Rating and Forecast

4.0

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$7.15M

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

-

PB Ratio (TTM)

1.25

Earnings Yield % (TTM)

-24.35%

Earnings Yield % (FWD)

-

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$2.77

Company Debt

Total Debt

-

LT Debt

-

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$6.88M

Debt to Equity

-

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$3.49

Close

$3.44

Volume / Avg.

40.50K / 198.55K

Day Range

$3.36 - $3.49

52 Wk Range

2.60 - 14.68

Market Cap

$29.49M

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

47

Short Interest

4.7%

Days to Cover

5.95

About

Sector

Health Care

Industry

Biotechnology

BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherap...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy BriaCell Therapeutics (BCTX) stock?

A

You can purchase shares of BriaCell Therapeutics (NASDAQ:BCTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are BriaCell Therapeutics (BCTX) competitors?

A

Other companies in BriaCell Therapeutics’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for BriaCell Therapeutics (BCTX) stock?

A

BriaCell Therapeutics has a consensus price target of $40.00.

Q

What is the current price for BriaCell Therapeutics (BCTX)?

A

The stock price for BriaCell Therapeutics (NASDAQ: BCTX) is $3.39 last updated August 14, 2026 at 5:17 PM EDT.

Q

Does BriaCell Therapeutics (BCTX) pay a dividend?

A

There are no upcoming dividends for BriaCell Therapeutics.

Q

When is BriaCell Therapeutics (NASDAQ:BCTX) reporting earnings?

A

BriaCell Therapeutics does not have any upcoming earnings scheduled.

Q

Is BriaCell Therapeutics (BCTX) going to split?

A

There is no upcoming split for BriaCell Therapeutics.

Q

What sector and industry does BriaCell Therapeutics (BCTX) operate in?

A

BriaCell Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.